Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Beta Drugs IPO and Siddharth Education IPO.
Beta Drugs IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Siddharth Education IPO is a SME Book Built Issue proposed to list at BSE SME.
| Beta Drugs IPO | Siddharth Education IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Book Built Issue |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Pantomath Capital Advisors Pvt Ltd | Gretex Corporate Services Limited |
| Registrar | Link Intime India Private Ltd | Kfin Technologies Limited |
| Market Maker | ||
| DRHP | DRHP  |
|
| RHP | RHP |
|
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Beta Drugs IPO is up to ₹19.52 Cr whereas the issue size of the Siddharth Education IPO is up to ₹10.88 Cr. The final issue price of Beta Drugs IPO is ₹85.00 per share and of Siddharth Education IPO is ₹35.00 per share.
| Beta Drugs IPO | Siddharth Education IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹30.00 per share | |
| Issue Price (Upper) | ₹35.00 per share | |
| Issue Price (Final) | ₹85.00 per share | ₹35.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 4000 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 22,96,000 shares | 31,08,000 shares |
| Issue Size Total (Amount) | up to ₹19.52 Cr | up to ₹10.88 Cr |
Beta Drugs IPO opens on Sep 29, 2017, while Siddharth Education IPO opens on Sep 29, 2017. The closing date of Beta Drugs IPO and Siddharth Education IPO is Oct 04, 2017, and Oct 05, 2017, respectively.
| Beta Drugs IPO | Siddharth Education IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 29, 2017 | Sep 29, 2017 |
| Issue Close | Oct 04, 2017 | Oct 05, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Beta Drugs IPO P/E ratio is , as compared to Siddharth Education IPO P/E ratio of .
| Beta Drugs IPO | Siddharth Education IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the Beta Drugs IPO retail investors (RII) are offered while in Siddharth Education IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Beta Drugs IPO and in Siddharth Education IPO.
| Beta Drugs IPO | Siddharth Education IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Beta Drugs IPO subscribed in total, whereas Siddharth Education IPO subscribed .
| Beta Drugs IPO | Siddharth Education IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
